| Key Financial Ratios of Chemo-Pharma Laboratories (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
2.28 |
8.00 |
0.32 |
3.73 |
1.67 |
|
| Diluted EPS (Rs.) |
2.28 |
8.00 |
0.32 |
3.73 |
1.67 |
|
| Cash EPS (Rs.) |
2.32 |
8.06 |
0.40 |
3.86 |
1.83 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
87.63 |
85.35 |
77.35 |
77.03 |
73.30 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
87.63 |
85.35 |
77.35 |
77.03 |
73.30 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| PBDIT/Share (Rs.) |
3.36 |
11.01 |
0.58 |
2.56 |
2.23 |
|
| PBIT/Share (Rs.) |
3.32 |
10.96 |
0.49 |
2.43 |
2.07 |
|
| PBT/Share (Rs.) |
3.32 |
10.96 |
0.49 |
2.43 |
2.07 |
|
| Net Profit/Share (Rs.) |
2.28 |
8.00 |
0.32 |
3.73 |
1.67 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| PBIT Margin (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| PBT Margin (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Net Profit Margin (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Return on Networth / Equity (%) |
2.60 |
9.37 |
0.40 |
4.84 |
2.27 |
|
| Return on Capital Employed (%) |
3.78 |
12.80 |
0.63 |
3.15 |
2.82 |
|
| Return on Assets (%) |
2.56 |
9.22 |
0.40 |
4.80 |
2.26 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
52.70 |
35.10 |
306.67 |
58.17 |
187.53 |
|
| Quick Ratio (X) |
52.70 |
35.10 |
306.67 |
58.17 |
187.53 |
|
| Inventory Turnover Ratio (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
8.07 |
3.64 |
-0.07 |
0.01 |
-8.19 |
|
| EV/Net Operating Revenue (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EV/EBITDA (X) |
16.02 |
2.21 |
-0.82 |
0.02 |
-24.49 |
|
| MarketCap/Net Operating Revenue (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
1.42 |
0.76 |
0.52 |
0.54 |
0.24 |
|
| Price/Net Operating Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Yield |
0.02 |
0.12 |
0.01 |
0.09 |
0.09 |
|
Source : Dion Global Solutions Limited
